Author Index ABADIE A. see ROMAN V. CAI S. see GHIASI H. ABO T. see MORODA T. CAMPBELL A.K. see TAYLOR K.M. ALI S. see CUNNINGHAM A.C. CARAYANNIOTIS G. see RAO V.P. ALLAIN F. see DENYS A. CARDONA A. see EDELMAN L. ALLER W.W. see SANCHEZ-GARCIA F.J. CARNEIRO C.R.W. see FEIJO G.C:S. AMEMIYA H. see SHINOMIYA T. CAULFIELD M.J. see DITULIO N.A. AMIRAND C. see ROMAN V. CHAABIHI H. see EDELMAN L. ANSORGE S. see REINHOLD D. CHABY R. see GIRARD R. AOI T., NAKANO H., TANAKA Y. & KAKIUCHI T. CHAIN B.M. see MARCINKIEWICZ J. Enhancement of antigen-presenting ability of B lymphoma cells CHAPMAN M.D. see RICHARDS D. by partial inhibition of protein synthesis through inducing B7-1 CHUI D. see ONG C.J. expression, 212 CHUNG K.F. see HACZKU A. AOYAGI T. see KAWAKAMI A. COLLINS HLL. see CROSS C.E. APRIL M.J. see DENAULT S. CONTI B. see OLIKOWSKY T. AURIAULT C. see WOLOWCZUK I. CORATO A. see MAZZA G. AZOUAOU N., PETROFSKY M., YOUNG LS. & CORRADIN G. see TOUJAS L. BERMUDEZ L.E. Mycobacterium avium infection in mice is CORRIGAN C. see TILL S. associated with time-related expression of Thl and Th2 CD4* COUTELIER J.P. see MAZZA G. T-lymphocyte response, 414 CROSS C.E., COLLINS H.L. & BANCROFT G.J. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate BAECHER-ALLAN C.M. see O'BRIEN D.P. ingestion of a defined CR3 ligand and complement-opsonized BANCROFT G.J. see CROSS C.E. Cryptococcus neoformans, 289 BANK U. see REINHOLD D. CUNHA F.Q. see SOUZA M.H.L.P. BARBOZA M.E. see LARREGINA A.T. CUNNINGHAM A.C., ZHANG J.-G., MOY J.V., ALIS. & BARNES P.J. see HACZKU A. KIRBY J.A. A comparison of the antigen-presenting capabilities BARTH R.K. see O'BRIEN D.P. of class II MHC-expressing human lung epithelial and BARTHOLOMEW M. see BRETT S.J. endothelial cells, 458 BEACOCK-SHARP H. see YOUNG J.L. BELL E.B. see HARGREAVES M. DAY M.J. see MAZZA G. BENBERNOU N., ESNAULT S., SHIN H.C.K., FEKKAR H. & DELACRE M. see WOLOWCZUK I. GUENOUNOU M. Differential regulation of IFN-y, IL-10 and DELCROS J.-G. see TOUJAS L. inducible nitric oxide synthase in human T cells by cyclic AMP- DELICE D. see JULIUS P. JR ' dependent signal transduction pathway, 361 DENAULT S., APRIL M.J. & STANKOVA J. Transcriptional BEPPU M. see KADENA T. activation of the interleukin-8 gene by platelet-activating factor BERMUDEZ L.E. see AZOUAOU N. in human peripheral blood monocytes, 297 BERNEMAN Z.N. see LARDON F. DENYS A., ALLAIN F., FOXWELL B. & SPIK G. Distribution BICE D. see SCHUYLER M. of cyclophilin B-binding sites in the subsets of human peripheral BLANCHARD D. see EDELMAN L. blood lymphocytes, 609 BLEEKER M.W.P., NETEA M.G., KULLBERG B.J., VAN DER DESROIS M. see SIMON A.K. VEN-JONGEKRUG J. & VAN DER MEER J.W.M. The DICKASON R. see TILL S. effects of dexamethasone and chlorpromazine on tumour necrosis DIEZ E. see TOUJAS L. factor-a, interleukin-1f, interleukin-1 receptor antagonist and DIULIO N.A., FAIRCHILD R.L. & CAULFIELD M.J. The anti- interleukin-10 in human volunteers, 548 erythrocyte autoimmune response of NZB mice. Identification of BODMER M. see SUITTERS A.J. two distinct autoantigens, 246 BOECKXTAENS C.J. see LARDON F. DOMSCHKE W. see LUGERING N. BORN W. see KELLY K.A. DONACHIE A.M. see KOMAI-KOMA M. BRAND H. see SUITTERS A.J. DOWNIE I. see SANDILANDS G.P. BRETT S.J., ROWAN W., SMITH M., BARTHOLOMEW M. & DUDHANE A. see OLIKOWSKY T. TITE J.P. Differential functional effects of a humanized anti- DUDLER L. see HEIN W.R. CD4 antibody on resting and activated human T cells, 346 DUGAS B. see ROMAN V. BRIGIDO M.M. see FEIJO G.C:S. DUGAS N. see ROMAN V. BRINKMAN V. & KRISTOFIC C. Massive production of Th2 DUMAS G. see EDELMAN L. cytokines by human CD4* effector T cells transiently expressing DURHAM S. see TILL S. the natural killer cell marker CD57/HNK1, 541 DUSCHL A. see GOEBELER M. BROCKER E.-B. see GOEBELER M. DUTZ J.P. see ONG C.J. BROWN W.R, RABBANI H., BUTLER J.E. & HAMMARSTROM L. Characterization of the bovine Cx EDELMAN L., MARGARITTE C., CHAABIHI H., gene, | MONCHATRE E., BLANCHARD D., CARDONA A.., BRYNIARSKI K. see MARCINKIEWICZ J. MORIN F., DUMAS G., PETRES S. & KACZOREK M. BUCKNALL R.C. see QUAYLE J.A. Obtaining a functional recombinant anti-rhesus (D) antibody BUHLING F. see REINHOLD D. using the baculovirus—insect cell expression system, 13 BUNGRE J. see TILL S. EDWARDS S.W. see QUAYLE J.A. BURNETT E.R. see SANDILANDS G.P. EGUCHI K. see KAWAKAMI A. BURNS N.P. JR see O-BRIEN D.P. EL AZAMI EL IDRISSI M. see MAZZA G. BUTLER J.E. see BROWN W.R EL-GHORR A.A. see HART P.H. 650 Author Index ELSON C.J. see MAZZA G. HEIN W.R. & DUDLER L. TCR yd” are prominent in normal ERICKSON K.L. see SUK K. bovine skin and express a diverse repertoire of antigen ERLANDSSON-HARRIS H. see SVELANDER L. receptors, 58 ESNAULT S. see BENBERNOU N. HENCKAERTS E. see LARDON F. HII C.S.T. see ROBINSON B.S. FAINBOIM L. see LARREGINA A.T. HIRST T.R. see NASHAR T.O. FAIRCHILD R.L. see DITULIO N.A. HITSUMOTO Y. see KAWAMOTO Y. FAUST J. see REINHOLD D. HOFFMANN M.K. see OLIKOWSKY T. FEIJO G.C.S., SABBAGA J., CARNEIRO C.R.W. & HOLERS V.M. see KAWAMOTO Y. BRIGIDO M.M. Variable region structure and Staphylococcal HOLT P.G. & THOMAS J.A. Steroids inhibit uptake and/or protein A binding specificity of a mouse monoclonal IgM anti- processing but not presentation of antigen by airway dendritic laminin-receptor antibody, 479 cells, 145 FEKKAR H. see BENBERNOU N. HORI T. see YAMABE T. FELDMANN M. see FIEHN C. HORIUCHI S., KOYANAGI Y., TANAKA Y., WAKI M., FERRANTE A. see ROBINSON B.S. MATSUMOTO A., ZHOU Y.W., YAMAMOTO M. & FIEHN C., PALEOLOG E.M. & FELDMANN M.. Selective YAMAMOTO N. Altered interleukin-2 receptor «-chain is enhancement of endothelial cell VCAM-1 expression by expressed in human T-cell leukaemia virus type-I-infected T-cell iww==««o_e|>iliiii > i ;>ee s interleukin-10 in the presence of activated leucocytes, 565 lines and human peripheral blood mononuclear cells of adult FINLAY-JONES J.J. see HART P.H. T-cell leukaemia patients through an alternative splicing FORTUNE F. see WARR K. mechanism, 28 xam FOULKES R. see SUITTERS A.J. HOROWITZ H. see OLIKOWSKY T. FOXWELL B. see DENYS A. HUANG T.-J. see HACZKU A. FUJISE S. see KADENA T. HUSTON D. see TILL S. GAO J.-X., MADRENAS J., ZENG W., ZHONG R. & GRANT D. Generation of dendritic cell-like antigen-presenting IIAI T. see MORODA T. cells in long-term mixed leucocyte culture: phenotypic and IKEBE H. see MATSUZAKI G. functional studies, 135 INOUYE S. see SAKAGUCHI M. GASTON J.S.H. see YOUNG J.L. GEORGE A.J.T. see PALMER D.B. GERVOIS N. see TOUJAS L. JAKSIC A. see HART P.H. GHIASI H., ROOPENIAN D.C., SLANINA S., CAI S., JOTEREAU F. see TOUJAS L. NESBURN A.B. & WECHSLER S.L. The importance of JUILLARD P. see KOSSODO S. MHC-I and MHC-II responses in vaccine efficacy against lethal JULIUS P. JR, KAGA M., PALMER Y., VYAS V., PRIOR L., herpes simplex virus type | challenge, 430 DELICE D. & RIGGS J. Recipient age determines the success GIANNINI S.L. see WOLOWCZUK I. of intraperitoneal transplantation of peritoneal cavity B cells, 383 GIBBONS A.E., SHELLAM G.R. & PRICE P. Correlation JULKUNEN I. see KESKINEN P. between natural killer cell activation in the bone marrow and haemopoietic dysfunction following cytomegalovirus infection of mice, 227 KACZOREK M. see EDELMAN L. GILLITZER R. see GOEBELER M. KADENA T., MATSUZAKI G., FUJISE S., KISHIHARA K.., ROOooerRRettttte ee n GIRARD R., PEDRON T. & CHABY R. Functional TAKIMOTO H., SASAKI M., BEPPU M., NAKAMURA §&. & lipopolysaccharide receptors of low affinity are constitutively NOMOTO K. TCRaf* CD4~ CD8°~ Tc ells differentiate expressed on mouse bone marrow cells, 391 extrathymically in an /ck-independent manner and participate in GOEBELER M., SCHNARR B., TOKSOY A., KUNZ M.., early response against Listeria monocytogenes infection through BROCKER E.-B., DUSCHL A. & GILLITZER R. interferon-y production, 511 Interleukin-13 selectively induces monocyte chemoattractant KAGA M. see JULIUS P. JR protein-1 synthesis and secretion by human endothelial cells. KAKIUCHI T. see AOI T. Involvement of IL-4R« and Stat6 phosphorylation, 450 KARP C.L. see MOLLER D.R. GOLDMAN M. see KOSSODO S. KATAOKA T., TOGASHI K., TAKAYAMA H., TAKAKU K. & GOODALL J.C. see YOUNG J.L. NAGAI K. Inactivation and proteolytic degradation of perforin GRABOWSKA A. see MARCINKIEWICZ J. within lytic granules upon neutralization of acidic pH, 493 GRANT D. see GAO J.-X. KAWABE Y. see KAWAKAMI A. GRAU G.E. see KOSSODO S. KAWACHI Y. see MORODA T. GREENLEE B.M. see MOLLER D.R. KAWAGUCHI-MIYASHATI M., NANNO M., SHIMADA &., GUENOUNOU M. see BENBERNOU N. NAGAOKA N., OKAKA Y., MATSUMOTO S., UMESAKI Y., MATSUOKA Y. & OHWAKI M. A step-wise HACZKU A., MACARY P., HUANG T.-J., TSUKAGOSHI H., expansion of intestinal intraepithelial T lymphocytes in BARNES P.J., KAY A.B., KEMENY D.M., CHUNG K.F. & association with microbial colonization is defined by sensitivity MOQBEL R. Adoptive transfer of allergen-specific CD4* T cells to cyclosporin A, 628 induces airway inflammation and hyperresponsiveness in Brown- KAWAKAMI A., EGUCHI K., MATSUOKA N., TSUBOI M., Norway rats, 176 URAYAMA S., KAWABE Y., AOYAGI T., MAEDA K. & HAMANO §S. see MATSUZAKI G. NAGATAKI S. Inhibitory effects of interleukin-10 on synovial HAMAOKA T. see KOSUGI A. cells of rheumatoid arthritis, 252 HAMMARSTROM L. see BROWN W.R KAWAMOTO Y., KOJIMA K., HITSUMOTO Y., OKADA H., HARGREAVES M. & BELL E.B. Identical expression of CD45R HOLERS V.M. & MIYAMA A. The serum resistance of isoforms by CD45RC* ‘revertant’ memory and CD45RC* naive malaria-infected erythrocytes, 7 CD4 T cells, 323 KAY A.B. see HACZKU A. HART P.H., JAKSIC A., SWIFT G., NORVAL M., see also TILL S. EL-GHORR A.A. & FINLAY-JONES J. J. Histamine KELLY K.A., O'BRIEN R. & BORN W. Reconstitution of SCID involvement in UVB- and cis-urocanic acid-induced systemic mice with haematopoietic precursors: a detailed analysis of yé suppression of contact hypersensitivity responses, 601 T-cell reconstitution, 65 HASHIMOTO M. see SAKAGUCHI M. KEMENY D.M. see HACZKU A. HASHIMOTO Y. see KOSUGI A. see also RICHARDS D. HATAKEYAMA K. see MORODA T. KERSTENS L.L. see LARDON F. Author Index 651 KESKINEN P., RONNI T., MATIKAINEN S., LEHTONEN A. & MACDONALD T.T. see MCDONALD S.A.C. JULKUNEN I. Regulation of HLA class I and II expression by MACFARLANE D.E., MANZEL L. & KRIEG A.M. interferons and influenza A virus in human peripheral blood Unmethylated CpG-containing oligodeoxynucleotides inhibit mononuclear cells, 421 apoptosis in WEHI-231 B lymphocytes induced by several agents: KIRBY J.A. see CUNNINGHAM A.C. evidence for blockade of apoptosis at a distal signalling step, 586 KISHIHARA K. see KADENA T. MACINTYRE N. see TERRY L.A. KITAOKA Y. see YAMABE T. MACPHERSON S.A. see SANDILANDS G.P. KLAGGE I., KOPP U. & KOCH N. Granulocyte—-macrophage MACSWEEN R.N.M. see SANDILANDS G.P. colony-stimulating factor elevates invariant chain expression in MADRENAS J. see GAO J.-X. immature myelomonocytic cell lines, 114 MAEDA K. see KAWAKAMI A. KLEINAU S. see SVELANDER L. MANZEL L. see MACFARLANE D.E. KOCH N. see KLAGGE I. MARCINKIEWICZ J., GRABOWSKA A., BRYNIARSKI K. & KOJIMA K. see KAWAMOTO Y. CHAIN B.M. Enhancement of CD4* T-cell-dependent KOLB J.-P. see ROMAN V. interleukin-2 production in vitro by murine alveolar KOLKOWSKI E. see LARREGINA A.T. macrophages: the role of leukotriene B,, 369 KOLSCH E. see SUDOWE S. MARGARITTE C. see EDELMAN L. cell KOMAI-KOMA M., DONACHIE A.M. & WILKINSON P.C. MARQUART H.V., RASMUSSEN J.M. & LESLIE R.G.Q. Antigen-specific chemotaxis of B cells, 579 Complement-activating ability of leucocytes from patients with KOPP U. see KLAGGE I. complement factor I deficiency, 486 KOSSODO S., MONSO C., JUILLARD P., VELU T., MARTH J.D. see ONG C.J. GOLDMAN M. & GRAU G. E. Interleukin-10 modulates MASTEN B. see SCHUYLER M. susceptibility in experimental cerebral malaria, 536 MATIKAINEN S. see KESKINEN P. KOSUGI A., NODA S., SAITOH S.I., NARUMIYA &., MATSUMOTO A. see HORIUCHI S. OGATA M., HASHIMOTO Y., TAKASE K., SAITO T. & MATSUMOTO S. see KAWAGUCHI-MIYASHATI M. HAMAOKA T. Subunit composition of pre-T-cell receptor MATSUOKA N. see KAWAKAMI A. complex analysed by monoclonal antibody against the pre-T-cell MATSUOKA Y. see KAWAGUCHI-MIYASHATI M. receptor chain, 618 MATSUZAKI G. see KADENA T. KOYANAGI Y. see HORIUCHI S. MATSUZAKI G., SONODA K.-H., MUKASA A., YAMADA H.., KOZLOV V.A. see SELEDTSOVA G.V. NAKAMURA T., IKEBE H., HAMANO S. & NOMOTO K. KRIEG A.M. see MACFARLANE D.E. The characterization of testicular cell (TC )-specific T-cell clones, KRISTOFIC C. see BRINKMAN V. induced by intratesticular Listeria monocytogenes infection: KUCHARZIK T. see LUGERING N. TC-specific T cells with atypical cytokine profile transfer orchitis, KULLBERG B.J. see BLEEKER M.W.P. 520 KUMAGAI K. see RIKIISHI H. MAZZA G., EL AZAMI EL IDRISSI M., COUTELIER J.P., ess KUNDU S.K. & MERIGAN T.C. Heterogeneity of cytokine CORATO A., ELSON C.J., PFAU C.J. & DAY M.J. Infection 3, 383 functions in HIV infection, 234 of C3HeB/FeJ mice with the docile strain of lymphocytic KUNZ M. see GOEBELER M. choriomeningitis virus induces autoantibodies specific for KURIMOTO M. see SAKAGUCHI M. erythrocyte Band 3, 239 MCCARTHY J.B. see YBARRONDO B. LANGERMANS J.A.M. see VAN FURTH A.M. MCCORMACK W.T. see SANCHEZ-GARCIA F.J. LARDON F., SNOECK H.-W., BERNEMAN Z.N., VAN MCDONALD S.A.C., PALMEN M.J.H.J., VAN REES E.P. & TENDELOO V.F.I., NIJS G., LENJOU M.., MACDONALD T. T. Characterization of the mucosal cell- HENCKAERTS E., BOECKXTAENS C.J., VANDENABEELE mediated immune response in IL-2 knockout mice before and te in P., KERSTENS L.L., VAN BOCKSTAELE D.R. & after the onset of colitis, 73 ugh VANHAM G.L.E.E. Generation of dendritic cells from bone MELO-FILHO A.A. see SOUZA M.H.L.P. marrow progenitors using GM-CSF, TNF-a, and additional MERIGAN T.C. see KUNDU S.K. cytokines: antagonistic effects of IL-4 and IFN-y and selective MESCHER M.F. see YBARRONDO B. involvement of TNF-« receptor-1, 553 MITSUYAMA M. see YANG J. LARREGINA A.T., MORELLI A.E., KOLKOWSKI E., MIYAMA A. see KAWAMOTO Y. C. & SANJUAN N., BARBOZA M.E. & FAINBOIM L. Pattern of MOLLER D.R., WYSOCKA M., GREENLEE B.M., MA X., forin cytokine receptors expressed by human dendritic cells migrated WAHL L., TRINCHIERI G. & KARP C.L. Inhibition of from dermal explants, 303 human interleukin-12 production by pentoxifylline, 197 LEE T.H. see RICHARDS D. MONCHATRE E. see EDELMAN L. LEES S. see TERRY L.A. MONSO C. see KOSSODO S. LEHNER T. see WARR K. MOQBEL R. see HACZKU A. LEHTONEN A. see KESKINEN P. MORELLI A.E. see LARREGINA A.T. vise LENDECKEL U. see REINHOLD D. MORIN F. see EDELMAN L. LENJOU M. see LARDON F. MORODA T., IIAI T., SUZUKI S., TSUKAHARA A., TADA T., vity LENZO J.C. see YERKOVICH S.T. NOSE M., HATAKEYAMA K., SEKI S., TAKEDA K.., LEONARD J. see SUITTERS A.J. WATANABE H. & ABO T. Autologous killing by a population LESLIE R.G.Q. see MARQUART H.V. of intermediate T-cell receptor cells and its NK1.1~ and NKI1.1~ LI X.-K. see SHINOMIYA T. subsets, using Fas ligand/Fas molecules, 219 vial LIMA A.A.M. see SOUZA M.H.L.P. MORODA T., KAWACHI Y., I[AI T.,. TSUKAHARA A., LIU Z.-X. see RIKIISHI H. SUZUKI S., TADA T., WATANABE H., HATAKEYAMA K. LUGERING A. see LUGERING N. & ABO T. Self-reactive forbidden clones are confined to LUGERING N., KUCHARZIK T., LUGERING A., WINDE G., pathways of intermediate T-cell receptor cell differentiation even SORG C., DOMSCHKE W. & STOLL R. Importance of under immunosuppressive conditions, 88 combined treatment with IL-10 and IL-4, but not IL-13, for MOY J.V. see CUNNINGHAM A.C. inhibition of monocyte release of the Ca**-binding protein MUKASA A. see MATSUZAKI G. CID MRP8/14, 130 MUSSENER A. see SVELANDER L. 5 LYERLY D.M. see SOUZA M.H.L.P. LYONS C.R. see SCHUYLER M. NAGAI K. see KATAOKA T. MA X. see MOLLER D.R. NAGAOKA N. see KAWAGUCHI-MIYASHATI M. MACARY P. see HACZKU A. NAGATAKI S. see KAWAKAMI A. 652 Author Index NAGOYA T. see SAKAGUCHI M. FAUST J., NEUBERT K. & ANSORGE S. Inhibitors of NAKAMURA S&S. see KADENA T. dipeptidyl peptidase IV induce secretion of transforming growth NAKAMURA T. see MATSUZAKI G. factor-B, in PWM-stimulated PBMC and Tc ells, 354 NAKANO H. see AOI T. RIBEIRO R.A. see SOUZA M.H.L.P. NAMIE S. see WARR K. RICHARDS D., CHAPMAN M.D., SASAMA J., LEE T.H. & NANNO M. see KAWAGUCHI-MIYASHATI M. KEMENY D.M. Immune memory in CD4* CD45RA* NARUMIYA S. see KOSUGI A. T cells, 274 NASH A.A. see TERRY L.A. RIGGS J. see JULIUS P. IR NASHAR T.O., HIRST T.R. & WILLIAMS N.A. Modulation of RIKIISHI H., OKAMOTO S., SUGAWARA S., TAMURA K., B-cell activation by the B subunit of Escherchia coli enterotoxin: LIU Z.-X. & KUMAGAI K. Superantigenicity of helper T-cell receptor interaction up-regulates MHC class I, B7, CD40, CD25 mitogen (SPM-2) isolated from culture supernatants of and ICAM-1, 572 Streptococcus pyogenes, 406 NESBURN A.B. see GHIASI H. RITTER M.A. see PALMER D.B. NETEA M.G. see BLEEKER M.W.P. ROBINSON B.S., HII C.S.T., POULOS A. & FERRANTE A. NEUBERT K. see REINHOLD D. Activation of neutral sphingomyelinase in human neutrophils by NIGI H. see SAKAGUCHI M. polyunsaturated fatty acids, 274 NIJS G. see LARDON F. ROBINSON D. see TILL S. NODA S. see KOSUGI A. ROCHA M.F.G. see SOUZA M.H.L.P. NOMOTO K. see KADENA T. ROMAN V., DUGAS N., ABADIE A., AMIRAND C., ZHAO H., see also MATSUZAKI G. DUGAS B. & KOLB J.-P. Characterization of a constitutive NORVAL M. see HART P.H. type III nitric oxide synthase in human U937 monocytic cells: NOSE M. see MORODA T. stimulation by soluble CD23, 643 O'BRIEN D.P., BAECHER-ALLAN C.M., BURNS N.P. JR, RONNI T. see KESKINEN P. ROOPENIAN D.C. see GHIASI H. SHASTRI N. & BARTH R.K. Elimination of T-cell-receptor ROWAN W. see BRETT S.J. B-chain diversity in transgenic mice restricts antigen-specific but ROYE O. see WOLOWCZUK I. not alloreactive responses, 375 O'BRIEN R. see KELLY K.A. RUBIO N. Interferon-y induces the expression of immediate early O’ROURKE A.M. see YBARRONDO B. genes c-fos and c-jun in astrocytes 560 OGATA M. see KOSUGI A. RUSSELL A.J. see SANDILANDS G.P. OHWAKI M. see KAWAGUCHI-MIYASHATI M. RUSSELL R:S. see RAO V.P. OKADA H. see KAWAMOTO Y. OKAKA Y. see KAWAGUCHI-MIYASHATI M. SABBAGA J. see FEIJO G.C:S. OKAMOTO S. see RIKIISHI H. SAITO T. see KOSUGI A. OKUBO Y. see YAMABE T. SAITOH S.I. see KOSUGI A. OLIKOWSKY T., WANG Z.-Q., DUDHANE A., SAKAGUCHI M., HASHIMOTO M., NIGI H., YASUEDA H.., HOROWITZ H., CONTI B. & HOFFMANN M.K. Two TAKAHASHI Y., WATANABE M., NAGOYA T., distinct pathways of human macrophage differentiation are TANIGUCHI Y., KURIMOTO M. & INOUYE S. Epitope mediated by interferon-y and interleukin-10, 104 specificity of IgE antibodies to a major allergen (Cryj 1) of OLVER S.D. see YERKOVICH S.T. Japanese cedar pollen in sera of humans and monkeys with ONG C.J., DUTZ J.P., CHUI D., TEH H.-S. & MARTH J.D. pollionosis, 161 CD45 enhances positive selection and is expressed at a high level SAMARIN D.M. see SELEDTSOVA G.V. in large, cycling, positively selected CD4* CD8* thymocytes, 95 SANCHEZ-GARCIA F.J., ALLER W.W. & MCCORMACK W.T. Impaired calcium mobilization and differential tyrosine PALEOLOG E.M. see FIEHN C. phosphorylation in intestinal intraepithelial lymphocytes, 81 PALMEN M.J.H.J. see MCDONALD S.A.C. SANDILANDS G.P., MACPHERSON S.A., BURNETT E.R., PALMER D.B., GEORGE A.J.T. & RITTER M.A. Selection of RUSSELL A.J., DOWNIE I. & MACSWEEN R.N.M. antibodies to cell surface determinants on mouse thymic Differential expression of CD32 isoforms following alloactivation epithelial cells using a phage display library, 473 of human Tc ells, 204 PALMER Y. see JULIUS P. JR SANJUAN N. see LARREGINA A.T. PARKHOUSE R.M.E. see WHITTALL J.T.D. SASAKI M. see KADENA T. PEACOCK C.D. see YERKOVICH S.T. SASAMA J. see RICHARDS D. PEDRON T. see GIRARD R. SCHMITT-VERHULST A.-M. see SIMON A.K. PETRES S. see EDELMAN L. SCHNARR B. see GOEBELER M. PETROFSKY M. see AZOUAOU N. SCHUYLER M., LYONS C.R., MASTEN B. & BICE D. PFAU C.J. see MAZZA G. Immunoglobulin response to intrapulmonary immunization of PORTER J.R. see SUITTERS A.J. asthmatics, 167 POULOS A. see ROBINSON B.S. SEKI S. see MORODA T. PRICE P. see GIBBONS A.E. SELEDTSOV V.I. see SELEDTSOVA G.V. see also YERKOVICH S.T. SELEDTSOVA G.V., SELEDTSOV V.1., TARABAN V.Y., PRIOR L. see JULIUS P. JR SAMARIN D.M. & KOZLOV V.A. A role for interferon-y and QUAYLE J.A., WATSON F., BUCKNALL R.C. & transforming growth factor-f in erythroid cell-mediated EDWARDS S.W. Neutrophils from the synovial fluid of patients regulation of nitric oxide production in macrophages, 109 SEMANA G. see TOUJAS L. with rheumatoid arthritis express the high affinity immunoglobulin G receptor, FeyRI (CD64): role of immune SHASTRI N. see O'BRIEN D.P. complexes and cytokines in induction of receptor expression, 266 SHAW S. see SUITTERS A.J. SHELLAM G.R. see GIBBONS A.E. RABBANI H. see BROWN W.R SHIMADA S. see KAWAGUCHI-MIYASHATI M. RADEMAEKERS A. see SUDOWE S. SHIN H.C.K. see BENBERNOU N. RAO V.P., RUSSELL R.S. & CARAYANNIOTIS G. Recruitment SHINNICK T. see WARR K. of multiple VB genes in the TCR repertoire against a single SHINOMIYA T., LI X.-K., AMEMIYA H. & SUZUKI S. An pathogenic thyroglobulin epitope, 623 immunosuppressive agent, FTY720, increases intracellular RASMUSSEN J.M. see MARQUART H.V. concentration of calcium ion and induces apoptosis in REINHOLD D., BANK U., BUHLING F., LENDECKEL U., HL-60, 594 Author Index 653 SIMON A.K., DESROIS M. & SCHMITT-VERHULST A.-M. TRINCHIERI G. see MOLLER D.R. wth Interferon regulatory factors during development of CD4 and TSUBOI M. see KAWAKAMI A. CD8 thymocytes, 340 TSUKAGOSHI H. see HACZKU A. SIPES D.G. see SUK K. TSUKAHARA A. see MORODA T. SLANINA S. see GHIASI H. SMITH M. see BRETT S.J. UMESAKI Y. see KAWAGUCHI-MIYASHATI M. SNOECK H.-W. see LARDON F. URAYAMA S&S. see KAWAKAMI A. SONODA K.-H. see MATSUZAKI G. USHERWOOD E.J. see TERRY L.A. SORG C. see LUGERING N. sell SOUZA M.H.L.P., MELO-FILHO A.A., ROCHA M.F.G., VAN BOCKSTAELE D.R. see LARDON F. LYERLY D.M., CUNHA F.Q., LIMA A.A.M. & VAN DER MEER J.W.M. see BLEEKER M.W.P. RIBEIRO R.A. The involvement of macrophage-derived tumour VAN DER VEN-JONGEKRUG J. see BLEEKER M.W.P. necrosis factor and lipoxygenase products on the neutrophil VAN DER ZEE R. see WARR K. recruitment induced by Clostridium difficile toxin B, 281 VAN FURTH A.M., VERHARD-SEIJMONSBERGEN E.M.., s by SPIK G. see DENYS A. VAN FURTH R. & LANGERMANS J.A.M. Effect of STANKOVA J. see DENAULT S. lisofylline and pentoxifylline on the bacterial-stimulated STOLL R. see LUGERING N. production of TNF-«, IL-1 and IL-10 by human leucocytes, 193 SUDOWE S., RADEMAEKERS A. & KOLSCH E. Antigen dose- VAN FURTH R. see VAN FURTH A.M. dependent predominance of either direct or sequential switch in VAN REES E.P. see MCDONALD S.A.C. IgE antibody responses, 464 VAN TENDELOO V.F.I. see LARDON F. “ev SUGAWARA S. see RIKIISHI H. VANDENABEELE P. see LARDON F. SUGIE K. see YAMABE T. VANHAM G.L.E.E. see LARDON F. SUITTERS A.J., SHAW S., WALES M.R., PORTER J.R., VELU T. see KOSSODO S. LEONARD J., WOODGER R., BRAND H., BODMER M. & VERHARD-SEIJMONSBERGEN E.M. see VAN FURTH A.M. FOULKES R. Immune enhancing effects of VYAS V. see JULIUS P. JR dehydroepiandrosterone and dehydroepiandrosterone sulphate and the role of steroid sulphate, 314 WAHL L. see MOLLER D.R. rly SUK K., SIPES D.G. & ERICKSON K.L. Enhancement of B-cell WAKI M. see HORIUCHI S. translocation gene-| expression by prostaglandin E, in WALES M.R. see SUITTERS A.J. macrophages and the relationship to proliferation, 121 WALKER S. see TILL S. SUZUKI S. see MORODA T. WANG Z.-Q. see OLIKOWSKY T. see also SHINOMIYA T. 7 WARR K., FORTUNE F., NAMIE S., SHINNICK T., VAN DER SVELANDER L., MUSSENER A., ERLANDSSON-HARRIS H. ZEE R., WILLIAMS G. & LEHNER T. T-cell epitopes & KLEINAU S. Polyclonal Th1 cells transfer oil-induced recognized within the 65000 MW hsp in patients with IgA arthritis, 260 nephropathy, 399 SWIFT G. see HART P.H. WATANABE H. see MORODA T. WATANABE M. see SAKAGUCHI M. TADA T. see MORODA T. WATSON F. see QUAYLE J.A. TAKAHASHI Y. see SAKAGUCHI M. WECHSLER S.L. see GHIASI H. TAKAKU K. see KATAOKA T. WHITTALL J.T.D. & PARKHOUSE R.M.E. Changes in swine TAKAKURA K. see YAMABE T. macrophage phenotype after infection with African swine fever TAKASE K. see KOSUGI A. virus: cytokine production and responsiveness to interferon-y and W.T. TAKAYAMA H. see KATAOKA T. lipopolysaccharide, 444 TAKEDA K. see MORODA T. WILKINSON P.C. see KOMAI-KOMA M. TAKEDA S&S. see YAMABE T. WILLIAMS G. see WARR K. TAKIMOTO H. see KADENA T. WILLIAMS N.A. see NASHAR T.O. TAMURA K. see RIKISHI H. WINDE G. see LUGERING N. ation TANAKA Y. see AOI T. WOLOWCZUK I., DELACRE M., ROYE O., GIANNINI S.L. & see also HORIUCHI S. AURIAULT C. Interleukin-7 in the skin of Schistosoma TANIGUCHI Y. see SAKAGUCHI M. mansoni-infected mice is associated with a decrease in TARABAN V.Y. see SELEDTSOVA G.V. interferon-y production and leads to an aggravation of the TAYLOR K.M., TRIMBY A.R. & CAMPBELL A.K. Mutation of disease, 35 recombinant complement component C9 reveals the significance WOODGER R. see SUITTERS A.J. of the N-terminal region for polymerization, 20 WYSOCKA M. see MOLLER D.R. TEH H.-S. see ONG C.J. of TERRY L.A., USHERWOOD E.J., LEES S.. MACINTYRE N. & YAMABE T., TAKAKURA K., SUGIE K., KITAOKA Y.., NASH A.A. Immune response to murine cell lines of glial origin TAKEDA S., OKUBO Y., TESHIGAWARA K., YODOI J. & transplanted into the central nervous system of adult mice, 436 HORI T. Induction of the 2B9 antigen/dipeptidyl peptidase TESHIGAWARA K. see YAMABE T. IV/CD26 on human natural killer cells by IL-2, IL-12 or IL-15, THOMAS J.A. see HOLT P.G. 151 and TILL S., DURHAM S., DICKASON R., HUSTON D., YAMADA H. see MATSUZAKI G. BUNGRE J., WALKER S., ROBINSON D., KAY A.B. & YAMAMOTO M. see HORIUCHI S. CORRIGAN C. IL-13 production by allergen-stimulated T cells YAMAMOTO N. see HORIUCHI S. is increased in allergic disease and associated with IL-5, but not YANG J. & MITSUYAMA M. An essential role for the IFN-y expression, 53 endogenous interferon-y in the generation of protective T cells TITE J.P. see BRETT S.J. against Mycobacterium bovis BCG in mice, 529 TOGASHI K. see KATAOKA T. YASUEDA H. see SAKAGUCHI M. TOKSOY A. see GOEBELER M. YBARRONDO B., O'ROURKE A.M., MCCARTHY J.B. & TOUSJAS L., DELCROS J.-G., DIEZ E., GERVOIS N., MESCHER M.F. Cytotoxic T-lymphocyte interaction with SEMANA G., CORRADIN G. & JOTEREAU F. Human fibronectin and vitronectin: activated adhesion and cosignalling, monocyte-derived macrophages and dendritic cells are 186 comparably effective in vitro in presenting HLA class I-restricted YERKOVICH S.T., OLVER S.D., LENZO J.C., PEACOCK C.D. exogenous peptides, 635 & PRICE P. The roles of tumour necrosis factor-a, interleukin-1 TRIMBY A.R. see TAYLOR K.M. and interleukin-12 in murine cytomegalovirus infection, 45 654 Author Index YODOI J. see YAMABE T. ZENG W. see GAO J.-X. YOUNG J.L., GOODALL J.C., BEACOCK-SHARP H. & ZHANG J.-G. see CUNNINGHAM A.C. GASTON J.S.H. Human yé T-cell recognition of Yersinia ZHAO H. see ROMAN V. enterocolitica, 503 ZHONG R. see GAO J.-X. YOUNG LSS. see AZOUAOU N. ZHOU Y.W. see HORIUCHI S. Subject Index African swine fever virus: Dendritic cell generation: effects on swine macrophages, 444 effects of cyclosporin on, 553 Anti-CD4 antibody, humanized: Dendritic cell-like antigen-presenting cells: effects on human T cells, 346 in long-term mixed-leucocyte culture, 135 Antigen presentation: Dendritic cells, airway: by B-lymphoma cells, 212 effect of steroids on, 145 by lung epithelial and endothelial cells, 458 Dendritic cells, dermal: Apoptosis: cytokine receptors, 303 role of oligodeoxynucleotides, 586 Dipeptidyl peptidase IV inhibitors: Arthritis, oil induced: effects on peripheral blood mononuclear cells and T cells, 354 transfer by polyclonal T-helper | cells, 260 Arthritis, rheumatoid: Epitope specificity: neutrophil FceyRI expression, 266 of immunoglobulin E antibodies to Japanese cedar pollen Asthma: antigen, 161 antibody response to keyhole limpets haemocyanin, 167 Erythrocytes, malaria infected: Autoantibodies, erythrocyte specific: serum resistance, 7 in lymphocytic choriomeningitis virus-infected mice, 239 Autoantigens: Factor I deficiency: in NZB mice, 246 complement-activating activity in patients with, 486 Autologous killing: Forbidden clones, self-reactive: and intermediate T-cell receptor cells, 219 under immunosuppression, 88 Autoreactive T-cell clones: induced by Listeria monocytogenes infection, 520 Glial origin cell lines: immune response to, 436 B-cell activation by the B subunit of Escherchia coli enterotoxin, 572 B-cell translocation gene-1 expression: Herpes simplex virus-1 vaccine: enhancement by prostaglandin E,, 121 efficacy in knockout mice, 430 Human immunodeficiency virus infection: Ca, bovine: heterogeneity of cytokine functions, 234 characterization, | Human leucocyte antigen expression: Calcium-binding protein MRP8/14: regulation by interferon and influenza A, 421 release by monocytes, 130 Hyperresponsiveness, airway: CD26, on human natural killer cells: adoptive transfer, 176 by cytokines, 151 CD32 isoforms: Immune memory: differential expression following alloactivation, 204 in CD4* CD45RA* T cells, 331 CD45: Immunoglobulin E responses: regulation of thymic positive selection, 95 effects of antigen dose, 464 CD45RC isoform expression: Interferon regulatory factors: in CD4 T cells, 323 in thymic development, 340 Chemotaxis, antigen specific: Interferon-y and transforming growth factor-B: of B cells, 579 role in nitric oxide production in macrophages, 109 Clostridium difficile toxin B: Interferon-y: induction of neutrophil migration, 281 generation of immunity to bacillus Calmette-Guérin, 529 Colitis: induction of c-fos and c-jun in astrocytes, 560 in interleukin-2 knockout mice, 73 Interleukin-2, by alveolar macrophages: Complement C9: role of leukotriene B,, 369 significance of N-terminus for polymerization, 20 Interleukin-2Ra: Contact hypersensitivity, suppression: altered expression in human T-cell lymphotropic virus type-I- role of histamine, 601 infected T cells, 28 CR3-mediated phagocytosis: Interleukin-7: effect of cytokines, 289 in Schistosoma mansoni infection, 35 Cyclic AMP-dependent cytokine production, 361 Interleukin-8 gene: Cyclosporin B binding sites: transcriptional activation by platelet-activating factor, 297 in human lymphocyte subsets, 609 Interleukin-10: Cytokine production, human: and synovial cells, 252 effect of dexamethasone and chlorpromazine, 548 modulation of susceptibility to cerebral malaria, 536 Cytomegalovirus infection, murine: Interleukin-12, human: roles of tumour necrosis factor-a, interleukin-1 and inhibition of production by pentoxifylline, 197 interleukin-12, 45 Interleukin-13: Cytotoxic T-lymphocyte interaction: induction of monocyte chemoattractant protein-1 expression, 450 with fibronectin and vitronectin, 186 Interleukin-13 production: by allergen-stimulated T cells, 53 Dehydroepiandrosterone: Intracellular calcium: immune-enhancing effects, 314 increased by FTY720, 594 655 656 Subject Index Intraepithelial lymphocytes: Sphingomyelinase activation: signal transduction in, 81 in neutrophils, 274 Intreepithelial lymphocytes, activation: Superantigenicity of T-cell mitogen (SPM-2) from Streptococcus cyclosporin A sensitivity, 628 pyogenes, 406 Invariant chain expression: elevation by granulocyte—-macrophage colony-stimulating factor, T-cell clones induced by Listeria monocytogenes infection, 520 114 T-cell epitopes, in 65000 MW heat-shock protein: in immunoglobulin A, 399 Lipopolysaccharide: T-cell receptor complex subunit composition, 618 binding to mouse bone marrow cells, 391 T-cell receptor «6B * CD4~ CD8°~ T cells: Lisofylline and pentoxifylline: in listeriosis, 511 effect on cytokine production, 193 T-cell receptor B-chain diversity, elimination: effects on T-cell responses, 375 Macrophage differentiation: T-cell responses: mediation by interferon-y and interleukin-10, 104 to Mycobacterium avium, 414 Major histocompatability complex class I-restricted exogenous y6 T-cell reconstitution of SCID mice, 65 peptides: y6 T-cell recognition, human: presentation by macrophages and dendritic cells, 635 of Yersinia enterocolitica, 503 y5* T-cell receptor cells: Natural killer activity: in bovine skin, 58 in murine cytomegalovirus infection, 227 T-helper 2 cytokines: Nitric oxide synthase: production by CD57/HNK T cells, 541 inducible stimulation by soluble CD23, 643 Transplantation, peritoneal cavity B cells: Perforin: and age of recipient, 383 inactivation and degradation within lytic granules, 493 Phage display library: VB gene usage: selection of antibodies to thymic epithelial cells, 473 against thyroglobulin epitope, 623 Pre-T-cell-receptor complex: Variable region structure: subunit composition, 618 monoclonal immunoglobulin M anti-laminin receptor antibody, 479 Recombinant anti-rhesus antibody: Vascular cell adhesion molecule-1 expression: from baculovirus-expression system, 13 enhancement by interleukin-10, 565